Wuhan Hvsen Biotechnology Co (SZSE:300871) Beginning Cash Position : ¥229.5 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Wuhan Hvsen Biotechnology Co Beginning Cash Position?

Wuhan Hvsen Biotechnology Co's Beginning Cash Position for the quarter that ended in Mar. 2024 was ¥229.5 Mil.

Wuhan Hvsen Biotechnology Co's quarterly Beginning Cash Position declined from Sep. 2023 (¥210.3 Mil) to Dec. 2023 (¥119.4 Mil) but then increased from Dec. 2023 (¥119.4 Mil) to Mar. 2024 (¥229.5 Mil).

Wuhan Hvsen Biotechnology Co's annual Beginning Cash Position increased from Dec. 2021 (¥285.5 Mil) to Dec. 2022 (¥966.1 Mil) but then declined from Dec. 2022 (¥966.1 Mil) to Dec. 2023 (¥278.6 Mil).

Wuhan Hvsen Biotechnology Co Beginning Cash Position Historical Data

The historical data trend for Wuhan Hvsen Biotechnology Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hvsen Biotechnology Co Beginning Cash Position Chart

Wuhan Hvsen Biotechnology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

77.73

81.91

285.51

966.14

278.61

Wuhan Hvsen Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															278.61	237.47	210.26	119.41	229.51

Wuhan Hvsen Biotechnology Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Wuhan Hvsen Biotechnology Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Wuhan Hvsen Biotechnology Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Hvsen Biotechnology Co (SZSE:300871) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Hvsen Biotechnology Co Ltd (SZSE:300871) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

218 Zhangbai Road, Dongxihu District, Hubei Province, Wuhan, CHN, 430042

Website

http://www.whhsyy.com

Wuhan Hvsen Biotechnology Co Ltd is engaged in research and development, production and sales of veterinary drugs (including chemical drug preparations, raw materials, and Chinese medicine preparations), feed and additives. It produces tylvalosin raw material, various tylvalosin preparations, florfenicol preparations and other macrolides products.

Wuhan Hvsen Biotechnology Co (SZSE:300871) Headlines

No Headlines